Ledger.Open graph →
SEC Form D · filed June 25, 2015

Unum Therapeutics, Inc

Offering
$65.0M
Sold
$65.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Bruce Booth · Cambridge, MADirectorLiam Ratcliffe · Cambridge, MADirectorRyan Ferrero · Niwot, CODirectorMiller Welborn · Chattanooga, TNExec · DirectorLiam Ratcliffe · Cambridge, MADirectorBen Auspitz · Cambridge, MADirectorArti V. Finn · New York, NYDirectorRobert T. Johnston · Chattanooga, TNDirectorChristiana Stamoulis · Cambridge, MAExecCharles Wilson · Cambridge, MAExec · DirectorAlexis Bogo · Chattanooga, TNExec · DirectorChristiana Stamoulis · Cambridge, MAExecScott L. Probasco Iii · Chattanooga, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗